Biotech companies are investing millions to develop cannabinoid products as business data suggest the medical marijuana market will surpass recreational weed as a revenue generator. (Frost & Sullivan)
Confirmation that right-sided colon cancer has a worse prognosis as compared with left-sided disease, plus a suggestion for improving outcomes when cancer occurs on the right side. (American College of Surgeons)
Takeda Oncology announced that a phase III trial showed that treatment with brigatinib (Alunbrig) improved progression-free survival in ALK-positive non-small cell lung cancer as compared with crizotinib (Xalkori).
Could radiation therapy for early breast cancer be reduced to a single dose? (UT Southwestern)